Pharmaceutical Stocks List


Related Industries: Asset Management Biotechnology Business Services Chemicals Data Storage Diagnostics & Research Diversified Industrials Drug Manufacturers - General Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Farm & Construction Equipment Health Information Services Health Information Services Household & Personal Products Information Technology Services Internet Content & Information Lumber & Wood Production Medical Devices Medical Distribution Medical Instruments & Supplies Packaging & Containers Pharmaceutical Retailers Pharmaceutical Retailers Pollution & Treatment Controls Security & Protection Services Semiconductor Equipment & Materials Shell Companies Software - Application Specialty Chemicals Specialty Finance Steel Waste Management

Pharmaceutical Stocks Recent News

Date Stock Title
Nov 19 HTGC Hercules Capital: This 10% Yield Is Rock Solid
Nov 19 IPDN Professional Diversity Network stock slides after pricing $2M securities offerings
Nov 19 TEVA Teva Pharmaceutical Industries Limited (TEVA) Jefferies London Healthcare Conference (Transcript)
Nov 19 IPDN Professional Diversity Network, Inc. Announces Pricing of $2 Million Registered Direct Offering and Concurrent Private Placement
Nov 18 IPDN TalentAlly Partners with AI Geo to Launch Complimentary AI-Powered Interview Practice Sessions for Job Seekers
Nov 17 VVOS Vivos Therapeutics Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
Nov 16 AQST Is Aquestive Therapeutics (AQST) the Best Multibagger Stock to Buy Heading into 2025?
Nov 16 TEVA Plant-Based API Market Poised To Hit $52 Billion By 2034, Driven By Psychedelics And Cannabinoids
Nov 15 VVOS Vivos Therapeutics GAAP EPS of -$0.40, revenue of $3.86M
Nov 15 SABS These 2 “Strong Buy” Penny Stocks Are Set to Triple (or more), Say Analysts
Nov 15 VVOS Vivos Therapeutics Inc (VVOS) Q3 2024 Earnings Call Highlights: Revenue Growth and Strategic ...
Nov 15 VVOS Vivos Therapeutics, Inc. (VVOS) Q3 2024 Earnings Call Transcript
Nov 14 NEOG Neogen Chemicals Ltd (BOM:542665) Q2 2025 Earnings Call Highlights: Strong Revenue Growth ...
Nov 14 TEVA Druckenmiller's Duquesne closes some media holdings, loads into regional banks, among Q3 trades
Nov 14 VVOS Vivos Therapeutics Reports Third Quarter 2024 Financial Results and Provides Operational Update
Nov 14 NEOG Competitive Pressure, Macroeconomic Woes Weigh on NEOG Stock
Nov 14 VVOS Earnings Scheduled For November 14, 2024
Nov 13 VVOS Vivos Therapeutics Schedules Release of Third Quarter 2024 Financial Results and Conference Call
Nov 13 PJP Global Pharma carries the most overweight allocations in Nov – according to BofA’s Global FMS
Pharmaceutical

A medication (also referred to as medicine, pharmaceutical drug, or simply drug) is a drug used to diagnose, cure, treat, or prevent disease. Drug therapy (pharmacotherapy) is an important part of the medical field and relies on the science of pharmacology for continual advancement and on pharmacy for appropriate management.
Drugs are classified in various ways. One of the key divisions is by level of control, which distinguishes prescription drugs (those that a pharmacist dispenses only on the order of a physician, physician assistant, or qualified nurse) from over-the-counter drugs (those that consumers can order for themselves). Another key distinction is between traditional small-molecule drugs, usually derived from chemical synthesis, and biopharmaceuticals, which include recombinant proteins, vaccines, blood products used therapeutically (such as IVIG), gene therapy, monoclonal antibodies and cell therapy (for instance, stem-cell therapies). Other ways to classify medicines are by mode of action, route of administration, biological system affected, or therapeutic effects. An elaborate and widely used classification system is the Anatomical Therapeutic Chemical Classification System (ATC system). The World Health Organization keeps a list of essential medicines.
Drug discovery and drug development are complex and expensive endeavors undertaken by pharmaceutical companies, academic scientists, and governments. As a result of this complex path from discovery to commercialization, partnering has become a standard practice for advancing drug candidates through development pipelines. Governments generally regulate what drugs can be marketed, how drugs are marketed, and in some jurisdictions, drug pricing. Controversies have arisen over drug pricing and disposal of used drugs.

Browse All Tags